Table 9.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Liver Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 4,971 100.0% 22,344 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 42 0.8% 49 0.2%
OKT3 11 0.2% 63 0.3%
Thymoglobulin 898 18.1% 962 4.3%
Zenapax 397 8.0% 925 4.1%
Simulect 472 9.5% 1,416 6.3%
Campath 227 4.6% 86 0.4%
Rituximab 160 3.2% 8 0.0%
No Induction Drug Reported 2,948 59.3% 18,899 84.6%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.